Tenet Healthcare Corporation $THC Shares Bought by IQ EQ FUND MANAGEMENT IRELAND Ltd

IQ EQ FUND MANAGEMENT IRELAND Ltd raised its holdings in Tenet Healthcare Corporation (NYSE:THC) by 10.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,957 shares of the company’s stock after acquiring an additional 1,114 shares during the quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in Tenet Healthcare were worth $2,104,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the company. US Bancorp DE lifted its stake in Tenet Healthcare by 0.8% during the first quarter. US Bancorp DE now owns 8,620 shares of the company’s stock valued at $1,159,000 after buying an additional 68 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in Tenet Healthcare by 2.8% during the second quarter. Farther Finance Advisors LLC now owns 2,615 shares of the company’s stock valued at $460,000 after buying an additional 70 shares in the last quarter. Lindbrook Capital LLC lifted its stake in Tenet Healthcare by 5.3% during the first quarter. Lindbrook Capital LLC now owns 1,427 shares of the company’s stock valued at $192,000 after buying an additional 72 shares in the last quarter. Signaturefd LLC lifted its stake in Tenet Healthcare by 11.2% during the second quarter. Signaturefd LLC now owns 732 shares of the company’s stock valued at $129,000 after buying an additional 74 shares in the last quarter. Finally, Vista Investment Partners LLC lifted its stake in Tenet Healthcare by 0.3% during the second quarter. Vista Investment Partners LLC now owns 25,257 shares of the company’s stock valued at $4,445,000 after buying an additional 76 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on THC shares. Barclays increased their price target on shares of Tenet Healthcare from $208.00 to $229.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. Zacks Research lowered shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Wall Street Zen raised shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Saturday, July 26th. UBS Group increased their price target on shares of Tenet Healthcare from $230.00 to $238.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Finally, KeyCorp increased their price target on shares of Tenet Healthcare from $205.00 to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average price target of $209.25.

Insiders Place Their Bets

In other Tenet Healthcare news, CEO Saumya Sutaria sold 78,762 shares of Tenet Healthcare stock in a transaction on Wednesday, September 10th. The shares were sold at an average price of $190.78, for a total transaction of $15,026,214.36. Following the sale, the chief executive officer owned 368,683 shares in the company, valued at $70,337,342.74. The trade was a 17.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Lisa Y. Foo sold 8,000 shares of Tenet Healthcare stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $179.53, for a total transaction of $1,436,240.00. Following the sale, the executive vice president owned 20,878 shares in the company, valued at $3,748,227.34. This represents a 27.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 90,722 shares of company stock worth $17,161,015 over the last 90 days. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Trading Down 5.2%

Shares of Tenet Healthcare stock opened at $204.86 on Wednesday. The company’s fifty day simple moving average is $194.16 and its 200-day simple moving average is $171.31. The company has a market cap of $18.10 billion, a price-to-earnings ratio of 13.12, a PEG ratio of 0.93 and a beta of 1.52. The company has a current ratio of 1.71, a quick ratio of 1.63 and a debt-to-equity ratio of 2.39. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $217.43.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.33 by $0.37. The business had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. Tenet Healthcare’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the company posted $2.93 earnings per share. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. As a group, sell-side analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.